AstraZeneca $1.5B Cancer Investment, Aquamarine Light Show Over Spain, Neuralink approved for 2nd implant, Spinal Cord Recovery Breakthrough, and more...

(0:10): AstraZeneca to Invest $1.5B in Singapore for Revolutionary Cancer Drug Manufacturing Facility(1:43): Stunning Aquamarine Light Show Over Spain and Portugal Highlights Urgency for Better Space Object Detection(3:29): Neuralink Gains FDA Nod for Second Human Brain Implant, Targets 10 Patients by Year-End(5:31): Breakthrough Electrical Stimulation Device Offers New Hope for Spinal Cord Injury Recovery(8:07): Groundbreaking Research Reveals Superheated Core of 'Warm Neptune' WASP-107 b, Challenging Planet Formation TheoriesTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: Quartz